134 related articles for article (PubMed ID: 24693451)
1. Magnitude and Implications of Interfraction Variations in Organ Doses during High Dose Rate Brachytherapy of Cervix Cancer: A CT Based Planning Study.
Chakraborty S; Patel FD; Patil VM; Oinam AS; Sharma SC
ISRN Oncol; 2014; 2014():687365. PubMed ID: 24693451
[TBL] [Abstract][Full Text] [Related]
2. Interfraction variations in doses at OARs during three-dimensional high dose rate brachytherapy planning of cervix cancer.
Dhaka S; Rajani A; Kumar HS; Sharma N; Jakhar SL; Harsh K
J Cancer Res Ther; 2023; 19(5):1136-1141. PubMed ID: 37787275
[TBL] [Abstract][Full Text] [Related]
3. Inter-Fractional Variations in Volume and Radiation Dose to the Organs at Risk, High-Risk Clinical Target Volume and Implication of Image-Guided Adaptive Planning During Intracavitary Brachytherapy of Carcinoma Cervix.
Patil G; Br KK; Narayanan G
Cureus; 2022 Jan; 14(1):e21503. PubMed ID: 35223279
[TBL] [Abstract][Full Text] [Related]
4. Interfraction Dose Variations in Organs at Risk during CT-Based High-Dose-Rate Brachytherapy in Locally Advanced Carcinoma Cervix: An Early Experience of a Tertiary Care Center.
Sharma N; Semwal MK; Purkayastha A
J Med Phys; 2018; 43(2):136-140. PubMed ID: 29962692
[TBL] [Abstract][Full Text] [Related]
5. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
6. Assessment of cumulative external beam and intracavitary brachytherapy organ doses in gynecologic cancers using deformable dose summation.
Teo BK; Bonner Millar LP; Ding X; Lin LL
Radiother Oncol; 2015 May; 115(2):195-202. PubMed ID: 26002306
[TBL] [Abstract][Full Text] [Related]
7. Interfraction Variations in Organ Filling and Their Impact on Dosimetry in CT Image Based HDR Intracavitary Brachytherapy.
Rangarajan R
J Med Phys; 2018; 43(1):23-27. PubMed ID: 29628630
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique.
Yin G; Wang P; Lang J; Tian Y; Luo Y; Fan Z; Tam KY
J Contemp Brachytherapy; 2016 Jun; 8(3):221-32. PubMed ID: 27504132
[TBL] [Abstract][Full Text] [Related]
9. Interfraction dose deviation and catheter position in cervical interstitial and intracavitary image guided HDR brachytherapy.
Xu Y; Harris T; O'Farrell D; Cormack R; Lee L; King M; Buzurovic I
Med Dosim; 2022 Spring; 47(1):e1-e6. PubMed ID: 34702633
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of variation of interfraction doses to organs at risk during brachytherapy of cervical cancer.
Mukundan H; Tyagi K; Mukherjee D; Patel RK
Med J Armed Forces India; 2020 Apr; 76(2):201-206. PubMed ID: 32476719
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
12. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
13. Reporting of Inter Fraction Dose Variations of Organs at Risk in Computed Tomography-Guided High Dose Rate Intracavitary Brachytherapy in Carcinoma Cervix.
Nandi M; Pokala N; Perumareddy V; Sarkar S; Chanda S
J Med Phys; 2022; 47(4):394-397. PubMed ID: 36908489
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of dosimetric impact of inter-application and intra-application variations in fractionated high-dose-rate intra-cavitary brachytherapy of cervical cancer.
Pasha T; Hassan HN; Radhakrishna N; N MS; Varghese AS; Viswanath L; Valuvil NB; S S; H B G; Khaleel I; Palled SR; Thimmaiah N
J Contemp Brachytherapy; 2021 Dec; 13(6):627-632. PubMed ID: 35079248
[TBL] [Abstract][Full Text] [Related]
15. Problems and uncertainties with multiple point A's during multiple high-dose-rate intracavitary brachytherapy in carcinoma of the cervix.
Datta NR; Basu R; Das KJ; Rajasekar D; Pandey CM; Singh U; Ayyagari S
Clin Oncol (R Coll Radiol); 2004 Apr; 16(2):129-37. PubMed ID: 15074737
[TBL] [Abstract][Full Text] [Related]
16. Image guided radiation therapy boost in combination with high-dose-rate intracavitary brachytherapy for the treatment of cervical cancer.
Wang X; Li J; Wang P; Yuan K; Yin G; Wan B
J Contemp Brachytherapy; 2016 Apr; 8(2):122-7. PubMed ID: 27257416
[TBL] [Abstract][Full Text] [Related]
17. 2D to 3D Evaluation of Organs at Risk Doses in Intracavitary Brachytherapy for Cervical Cancer.
Tan YI; Choo BA; Lee KM
J Contemp Brachytherapy; 2010 Mar; 2(1):37-43. PubMed ID: 28031742
[TBL] [Abstract][Full Text] [Related]
18. Stability of Intracavitary Applicator Placement for HDR Brachytherapy of Cervix Cancer.
Balsdon A; Timotin E; Hunter R; Diamond K
J Med Imaging Radiat Sci; 2019 Sep; 50(3):441-448. PubMed ID: 31311722
[TBL] [Abstract][Full Text] [Related]
19. Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?
Patel S; Mehta KJ; Kuo HC; Ohri N; Patel R; Yaparpalvi R; Garg MK; Guha C; Kalnicki S
Brachytherapy; 2016; 15(2):185-90. PubMed ID: 26796601
[TBL] [Abstract][Full Text] [Related]
20. Appropriate Methodology for EBRT and HDR Intracavitary/Interstitial Brachytherapy Dose Composite and Clinical Plan Evaluation for Patients With Cervical Cancer.
Xu Z; Traughber BJ; Fredman E; Albani D; Ellis RJ; Podder TK
Pract Radiat Oncol; 2019 Nov; 9(6):e559-e571. PubMed ID: 31238167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
